We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
-17.24%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$10.9B
AUM Growth
-$6B
(-36%)
Cap. Flow
-$3.12B
Cap. Flow
% of AUM
-28.68%
Top 10 Holdings %
Top 10 Hldgs %
39.15%
Holding
1,272
New
54
Increased
189
Reduced
877
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$98.6M |
| 2 |
KraneShares CSI China Internet ETF
KWEB
|
+$28.5M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$23.8M |
| 4 |
Texas Instruments
TXN
|
+$9.35M |
| 5 |
VTNR
Vertex Energy, Inc
VTNR
|
+$8.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$612M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$211M |
| 3 |
Microsoft
MSFT
|
+$102M |
| 4 |
Broadcom
AVGO
|
+$90M |
| 5 |
Qualcomm
QCOM
|
+$84.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.25% |
| 2 | Financials | 12.23% |
| 3 | Energy | 7.74% |
| 4 | Healthcare | 5.49% |
| 5 | Industrials | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Insmed
INSM
$21.4B
| $3.61M | 0.03% |
183,175
-58,325
| -24% | -$1.22M |
|
352
Inovio Pharmaceuticals
INO
$55.7M
| $3.58M | 0.03% |
172,650
+7,665
| +5% | +$216K |
|
|
HZNP
353
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.57M | 0.03% |
44,731
-8,333
| -16% | -$789K |
|
|
SRNE
354
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $3.52M | 0.03% |
1,751,066
-719,616
| -29% | -$1.24M |
|
355
Zentalis Pharmaceuticals
ZNTL
$337M
| $3.52M | 0.03% |
125,247
+4,077
| +3% | +$108K |
|
356
Pinnacle Financial Partners Inc
PNFP
$15.9B
| $3.5M | 0.03% |
48,463
-29,187
| -38% | -$2.3M |
|
357
Gulfport Energy Corp
GPOR
$2.9B
| $3.5M | 0.03% |
44,063
+32,214
| +272% | +$2.99M |
|
358
Crown Castle
CCI
$33.3B
| $3.47M | 0.03% |
20,583
-3,675
| -15% | -$669K |
|
359
Everest Group
EG
$14.5B
| $3.46M | 0.03% |
12,359
-7,200
| -37% | -$2.04M |
|
|
Y
360
DELISTED
Alleghany Corp
Y
| $3.46M | 0.03% |
4,156
-2,526
| -38% | -$2.11M |
|
361
Ally Financial
ALLY
$13.2B
| $3.44M | 0.03% |
102,507
-67,476
| -40% | -$2.7M |
|
362
PMV Pharmaceuticals
PMVP
$59.2M
| $3.42M | 0.03% |
239,864
+67,764
| +39% | +$986K |
|
|
MNRL
363
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $3.39M | 0.03% |
137,764
+86,503
| +169% | +$2.38M |
|
364
Sherwin-Williams
SHW
$82.7B
| $3.39M | 0.03% |
15,150
-15,444
| -50% | -$3.96M |
|
|
SNV
365
DELISTED
Synovus
SNV
| $3.38M | 0.03% |
93,761
-59,650
| -39% | -$2.47M |
|
|
ISEE
366
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.37M | 0.03% |
350,616
+24,302
| +7% | +$305K |
|
|
IMGN
367
DELISTED
Immunogen Inc
IMGN
| $3.37M | 0.03% |
748,016
-104,868
| -12% | -$456K |
|
368
World Kinect Corp
WKC
$2.04B
| $3.35M | 0.03% |
163,637
+84,169
| +106% | +$2.07M |
|
369
Celldex Therapeutics
CLDX
$2.99B
| $3.34M | 0.03% |
123,806
-32,446
| -21% | -$942K |
|
370
Huntington Ingalls Industries
HII
$12.9B
| $3.33M | 0.03% |
15,303
-6,122
| -29% | -$1.29M |
|
371
Keysight
KEYS
$54.5B
| $3.33M | 0.03% |
24,171
-10,302
| -30% | -$1.47M |
|
|
DVAX
372
DELISTED
Dynavax Technologies
DVAX
| $3.33M | 0.03% |
264,417
-284,004
| -52% | -$3.02M |
|
373
Wintrust Financial
WTFC
$10.8B
| $3.31M | 0.03% |
41,242
-28,849
| -41% | -$2.48M |
|
374
Travere Therapeutics
TVTX
$5.2B
| $3.23M | 0.03% |
133,225
-28,018
| -17% | -$705K |
|
375
Bank OZK
OZK
$5.6B
| $3.19M | 0.03% |
85,056
-49,566
| -37% | -$1.96M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Rafferty Asset Management held 1,272 positions worth $10.9B, down 36% from $16.9B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Rafferty Asset Management withdrew a net $3.12B in Q2 2022, closing 147 positions and reducing 877 holdings. Its most notable exit was Xtrackers Harvest CSI 300 China A-Shares ETF, an estimated $24.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Energy.
Against the trend, Rafferty Asset Management opened a new position in Vertex Energy, Inc worth $7.26M.
- Rafferty Asset Management's largest Q2 2022 buy was Vertex Energy, Inc: 690,301 shares worth $7.26M.
- Rafferty Asset Management added most to iShares China Large-Cap ETF in Q2 2022, an estimated $98.6M increase.
- Rafferty Asset Management's biggest Q2 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $612M.
- Rafferty Asset Management fully exited Xtrackers Harvest CSI 300 China A-Shares ETF in Q2 2022, selling an estimated $24.8M.
- Rafferty Asset Management's ten largest holdings make up 39% of its $10.9B portfolio in Q2 2022.
- Rafferty Asset Management opened 54 new positions and closed 147 in Q2 2022.
- Rafferty Asset Management's portfolio value fell 36% quarter-over-quarter to $10.9B.
Based on Rafferty Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.